/PRNewswire/ Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronie s disease, or PD, and XIAFLEX® (collagenase.
/PRNewswire/ Endo International plc (OTC: ENDPQ) announced today that data from clinical studies of collagenase clostridium histolyticum (CCH) in patients.
/PRNewswire/ The specialty pharmaceuticals market size is expected to grow by USD 331.12 billion from 2022 to 2027. In addition, the momentum of the market.